113375-21-6

Upstream product

• 5433-01-2 1-bromo-3-isopropylbenzene 

Downstream Products

• 1433903-64-0 6-chloro-4-(3-isopropyl-phenyl)-2-pyrrolidin-1-yl-quinoline-3-carboxylic acid tert-butyl ester 
• 1433902-28-3 6-chloro-2-diethylamino-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic acid 
• 1433903-63-9 6-chloro-2-diethylamino-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic acid tert-butyl ester 
• 1433903-62-8 6-chloro-4-(3-isopropyl-phenyl)-2-trifluoromethanesulfonyloxy-quinoline-3-carboxylic acid tert-butyl ester 
• 1433903-61-7 6-chloro-4-(3-isopropyl-phenyl)-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid tert-butyl ester 
• 1433903-60-6 (2-amino-5-chloro-phenyl)-(3-isopropyl-phenyl)-methanone 
• 676135-11-8 8-(3-isopropylphenyl)-1,4-dioxa-spiro[4.5]decane-8-alcohol 
• 113375-20-5 (1S,5R,8R)-8-[2-Hydroxy-2-(3-isopropyl-phenyl)-ethyl]-1,5-dimethyl-6-oxa-bicyclo[3.2.1]octan-7-one 
• 94064-57-0 1-(3-Isopropyl-phenyl)-cyclohexen-⁽¹⁾ 
• 4501-41-1 (3-Isopropyl-phenyl)-cyclohexan 

Relevant academic research and scientific papers

OXIME DERIVATIVE SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a colletion of diseases, disorders, and conditions associated with abnormal deposition of A-beta protei

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.